Zuora (ZUO) 10-Q 7 Dec 23 2024 Q3 Quarterly report Financial data

Cover

Cover - shares shares in Millions	9 Months Ended
	Oct. 31, 2023	Nov. 30, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2023
Document Transition Report	false
Entity File Number	001-38451
Entity Registrant Name	Zuora, Inc
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-5530976
Entity Address, Address Line One	101 Redwood Shores Parkway
Entity Address, City or Town	Redwood City
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94065
City Area Code	888
Local Phone Number	976-9056
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	ZUO
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001423774
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		135
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		8.1

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 414,832	$ 203,239
Short-term investments	78,905	183,006
Accounts receivable, net of allowance for credit losses of $2,071 and $4,001 as of October 31, 2023 and January 31, 2023, respectively	78,297	91,740
Deferred commissions, current portion	15,298	16,282
Prepaid expenses and other current assets	23,554	24,285
Total current assets	610,886	518,552
Property and equipment, net	25,570	27,159
Operating lease right-of-use assets	25,296	22,768
Purchased intangibles, net	10,689	13,201
Deferred commissions, net of current portion	26,658	28,250
Goodwill	55,000	53,991
Other assets	4,035	4,677
Total assets	758,134	668,598
Current liabilities:
Accounts payable	465	1,073
Accrued expenses and other current liabilities	27,810	103,678
Accrued employee liabilities	30,992	30,483
Deferred revenue, current portion	158,407	167,145
Operating lease liabilities, current portion	7,396	9,240
Total current liabilities	225,070	311,619
Long-term debt	356,645	210,403
Deferred revenue, net of current portion	1,719	442
Operating lease liabilities, net of current portion	38,060	37,924
Deferred tax liabilities	3,723	3,717
Other long-term liabilities	7,340	7,333
Total liabilities	632,557	571,438
Commitments and contingencies (Note 13)
Stockholders’ equity:
Additional paid-in capital	936,147	859,482
Accumulated other comprehensive loss	(1,808)	(919)
Accumulated deficit	(808,776)	(761,417)
Total stockholders’ equity	125,577	97,160
Total liabilities and stockholders’ equity	758,134	668,598
Class A common stock
Stockholders’ equity:
Common stock	13	13
Class B common stock
Stockholders’ equity:
Common stock	$ 1	$ 1

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 2,071	$ 4,001

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue:
Total revenue	$ 109,849	$ 101,072	$ 320,992	$ 293,046
Cost of revenue:
Total cost of revenue	35,028	40,280	110,155	115,164
Gross profit	74,821	60,792	210,837	177,882
Operating expenses:
Research and development	27,504	28,413	79,428	77,639
Sales and marketing	40,245	46,973	124,488	132,576
General and administrative	15,893	19,327	54,160	55,433
Total operating expenses	83,642	94,713	258,076	265,648
Loss from operations	(8,821)	(33,921)	(47,239)	(87,766)
Change in fair value of debt conversion and warrant liabilities	6,997	452	2,241	9,348
Interest expense	(5,610)	(4,444)	(14,604)	(10,647)
Interest and other income (expense), net	2,272	1,187	13,639	98
Loss before income taxes	(5,162)	(36,726)	(45,963)	(88,967)
Income tax provision	340	308	1,396	1,145
Net loss	(5,502)	(37,034)	(47,359)	(90,112)
Comprehensive loss:
Foreign currency translation adjustment	(696)	(973)	(1,383)	(1,648)
Unrealized (loss) gain on available-for-sale securities	(18)	(337)	494	(1,013)
Comprehensive loss	$ (6,216)	$ (38,344)	$ (48,248)	$ (92,773)
Net loss per share, basic (in dollars per share)	$ (0.04)	$ (0.28)	$ (0.34)	$ (0.69)
Net loss per share, diluted (in dollars per share)	$ (0.04)	$ (0.28)	$ (0.34)	$ (0.69)
Weighted-average shares outstanding used in calculating net loss per share, basic (in shares)	141,488	132,579	138,789	130,461
Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares)	141,488	132,579	138,789	130,461
Subscription
Revenue:
Total revenue	$ 98,048	$ 86,567	$ 283,232	$ 248,878
Cost of revenue:
Total cost of revenue	20,378	21,727	62,304	60,024
Professional services
Revenue:
Total revenue	11,801	14,505	37,760	44,168
Cost of revenue:
Total cost of revenue	$ 14,650	$ 18,553	$ 47,851	$ 55,140

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Class A common stock	Class B common stock	Common Stock Class A common stock	Common Stock Class B common stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2022				119,008	9,048
Beginning balance at Jan. 31, 2022	$ 170,607			$ 12	$ 1	$ 734,149	$ (108)	$ (563,447)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				1,276	(1,276)
Issuance of common stock upon exercise of stock options (in shares)				49	349
Issuance of common stock upon exercise of stock options	2,097					2,097
RSU releases (in shares)				4,418
RSU releases	1	$ 1
Issuance of common stock under the ESPP (in shares)				615
Issuance of common stock under the ESPP	4,485					4,485
Charitable donation of stock (in shares)				101
Charitable donation of stock	1,000					1,000
Stock-based compensation	80,045					80,045
Issuance of warrants	18,442					18,442
Other comprehensive loss	(2,661)						(2,661)
Net loss	(90,112)							(90,112)
Ending balance (in shares) at Oct. 31, 2022				125,467	8,121
Ending balance at Oct. 31, 2022	183,904			$ 13	$ 1	840,218	(2,769)	(653,559)
Beginning balance (in shares) at Jul. 31, 2022				123,833	8,122
Beginning balance at Jul. 31, 2022	192,665			$ 12	$ 1	810,636	(1,459)	(616,525)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				111	(111)
Issuance of common stock upon exercise of stock options (in shares)					110
Issuance of common stock upon exercise of stock options	575					575
RSU releases (in shares)				1,523
RSU releases	1	$ 1
Stock-based compensation	29,007					29,007
Other comprehensive loss	(1,310)						(1,310)
Net loss	(37,034)							(37,034)
Ending balance (in shares) at Oct. 31, 2022				125,467	8,121
Ending balance at Oct. 31, 2022	183,904			$ 13	$ 1	840,218	(2,769)	(653,559)
Beginning balance (in shares) at Jan. 31, 2023				127,384	8,121
Beginning balance at Jan. 31, 2023	$ 97,160			$ 13	$ 1	859,482	(919)	(761,417)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				220	(220)
Issuance of common stock upon exercise of stock options (in shares)	215				214
Issuance of common stock upon exercise of stock options	$ 1,000					1,000
RSU and PSU releases (in shares)				6,464
Issuance of common stock under the ESPP (in shares)				911
Issuance of common stock under the ESPP	4,765					4,765
Stock-based compensation	77,973					77,973
Reclassification of warrants, net of allocated debt issuance costs, to Accrued expenses and other current liabilities	(7,073)					(7,073)
Other comprehensive loss	(889)						(889)
Net loss	(47,359)							(47,359)
Ending balance (in shares) at Oct. 31, 2023		135,000	8,100	134,979	8,115
Ending balance at Oct. 31, 2023	125,577			$ 13	$ 1	936,147	(1,808)	(808,776)
Beginning balance (in shares) at Jul. 31, 2023				132,448	8,119
Beginning balance at Jul. 31, 2023	112,727			$ 13	$ 1	917,081	(1,094)	(803,274)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of Class B common stock to Class A common stock (in shares)				17	(17)
Issuance of common stock upon exercise of stock options (in shares)					13
Issuance of common stock upon exercise of stock options	38					38
RSU and PSU releases (in shares)				2,514
Stock-based compensation	26,101					26,101
Reclassification of warrants, net of allocated debt issuance costs, to Accrued expenses and other current liabilities	(7,073)					(7,073)
Other comprehensive loss	(714)						(714)
Net loss	(5,502)							(5,502)
Ending balance (in shares) at Oct. 31, 2023		135,000	8,100	134,979	8,115
Ending balance at Oct. 31, 2023	$ 125,577			$ 13	$ 1	$ 936,147	$ (1,808)	$ (808,776)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Cash flows from operating activities:
Net loss	$ (47,359)	$ (90,112)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization and accretion	13,684	13,725
Stock-based compensation	77,973	80,045
Provision for credit losses	457	1,403
Donation of common stock to charitable foundation	0	1,000
Amortization of deferred commissions	14,415	14,250
Reduction in carrying amount of right-of-use assets	4,876	5,859
Change in fair value of debt conversion and warrant liabilities	(2,241)	(9,348)
Change in fair value of contingent consideration	0	(1,800)
Other	2,630	575
Changes in operating assets and liabilities:
Accounts receivable	12,476	5,666
Prepaid expenses and other assets	878	(2,454)
Deferred commissions	(12,013)	(15,418)
Accounts payable	(634)	3,415
Accrued expenses and other liabilities	(82,904)	2,819
Accrued employee liabilities	509	282
Deferred revenue	(7,461)	(2,607)
Operating lease liabilities	(10,962)	(9,979)
Net cash used in operating activities	(35,676)	(2,679)
Cash flows from investing activities:
Purchases of property and equipment	(6,913)	(8,471)
Purchases of short-term investments	(66,665)	(205,464)
Maturities of short-term investments	175,128	89,013
Cash paid for acquisition	(4,524)	(41,000)
Net cash provided by (used in) investing activities	97,026	(165,922)
Cash flows from financing activities:
Proceeds from issuance of convertible senior notes, net of issuance costs	145,861	233,901
Proceeds from issuance of common stock upon exercise of stock options	1,000	2,097
Proceeds from issuance of common stock under employee stock purchase plan	4,765	4,485
Principal payments on debt	0	(1,480)
Net cash provided by financing activities	151,626	239,003
Effect of exchange rates on cash and cash equivalents	(1,383)	(1,648)
Net increase in cash and cash equivalents	211,593	68,754
Cash and cash equivalents, beginning of period	203,239	113,507
Cash and cash equivalents, end of period	414,832	182,261
Supplemental disclosure of non-cash investing and financing activities:
Property and equipment purchases accrued or in accounts payable	$ 68	$ 64

Overview and Basis of Presentat

Overview and Basis of Presentation	9 Months Ended
	Oct. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview and Basis of Presentation	Note 1. Overview and Basis of Presentation Description of Business Zuora, Inc. was incorporated in the state of Delaware in 2006 and began operations in 2007. Zuora’s fiscal year ends on January 31. Zuora is headquartered in Redwood City, California. Zuora provides a cloud-based subscription management platform, built to help companies monetize new services and operate dynamic, recurring revenue business models. Our solutions enable companies across multiple industries and geographies to launch, manage and scale a subscription business, automating the quote-to-cash and revenue recognition process, including quoting, billing, collections and revenue recognition, and improving the subscriber experience. With Zuora’s solutions, businesses can change pricing and packaging for products and services to grow and scale, efficiently comply with revenue recognition standards, analyze customer data to optimize their subscription offerings, and build meaningful relationships with their subscribers. On September 2, 2022, Zuora acquired Zephr, a leading subscription experience platform used by global digital publishing and media companies. Additional information regarding the Zephr acquisition is contained in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023, filed with the Securities and Exchange Commission (SEC) on April 3, 2023 (Annual Report on Form 10-K). References to “Zuora”, “us”, “our”, or “we” in these notes refer to Zuora, Inc. and its subsidiaries on a consolidated basis. Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements, which include the accounts of Zuora and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States (GAAP) and applicable rules and regulations of the SEC regarding interim financial reporting. All intercompany balances and transactions have been eliminated in consolidation. The unaudited condensed consolidated balance sheet as of January 31, 2023 included herein was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of comprehensive loss, statements of cash flows and statements of stockholders' equity for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2024 or any future period. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023. Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements, as well as reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates. Our most significant estimates and assumptions are related to revenue recognition with respect to the determination of the relative standalone selling prices for our services; the expected period of benefit over which deferred commissions are amortized; valuation of stock-based awards and our convertible senior notes and warrants; estimates of allowance for credit losses; estimates of the fair value of goodwill and long-lived assets when evaluating for impairments and for assets acquired from acquisitions; useful lives of intangibles and other long-lived assets; and the valuation of deferred income tax assets and contingencies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results may differ materially from these estimates under different assumptions or conditions.

Summary of Significant Accounti

Summary of Significant Accounting Policies and Recent Accounting Pronouncements	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies and Recent Accounting Pronouncements	Note 2. Summary of Significant Accounting Policies and Recent Accounting Pronouncements Our significant accounting policies are discussed in Note 2. Summary of Significant Accounting Policies and Recent Accounting Pronouncements

Investments

Investments	9 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Investments	Note 3. Investments The amortized costs, unrealized gains and losses and estimated fair values of our short-term investments were as follows (in thousands): October 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. government securities $ 18,841 $ — $ (23) $ 18,818 Corporate bonds 8,095 — (11) 8,084 Commercial paper 52,051 — (48) 52,003 Total short-term investments $ 78,987 $ — $ (82) $ 78,905 January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. government securities $ 34,865 $ — $ (377) $ 34,488 Corporate bonds 41,974 — (189) 41,785 Commercial paper 102,720 — — 102,720 Foreign government securities 4,023 — (10) 4,013 Total short-term investments $ 183,582 $ — $ (576) $ 183,006 There were no material realized gains or losses from sales of marketable securities that were reclassified out of accumulated other comprehensive loss into investment income during the three and nine months ended October 31, 2023 and 2022. We had no significant unrealized losses on our available-for-sale securities as of October 31, 2023 and January 31, 2023, and we do not expect material credit losses on our current investments in future periods. All securities had stated effective maturities of less than one year as of October 31, 2023.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 4. Fair Value Measurements The accounting guidance for fair value measurements establishes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value as follows: Level input Input definition Level 1 Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets Level 2 Inputs other than quoted prices included within Level 1 that are observable for the asset or liability through corroboration with market data at the measurement date Level 3 Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date In general, and where applicable, we use quoted prices in active markets for identical assets or liabilities to determine fair value. If quoted prices in active markets for identical assets or liabilities are not available to determine fair value, then we use quoted prices for similar assets and liabilities or inputs other than the quoted prices that are observable either directly or indirectly. The following tables summarize our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis (in thousands): October 31, 2023 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 355,951 $ — $ — $ 355,951 Treasury bills 4,959 — — 4,959 Total cash equivalents $ 360,910 $ — $ — $ 360,910 Short-term investments: U.S. government securities $ — $ 18,818 $ — $ 18,818 Corporate bonds — 8,084 — 8,084 Commercial paper — 52,003 — 52,003 Total short-term investments $ — $ 78,905 $ — $ 78,905 Liabilities: Warrant liability $ — $ — $ 8,592 $ 8,592 Debt conversion liability — — 5,773 5,773 Total liabilities $ — $ — $ 14,365 $ 14,365 January 31, 2023 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 184,580 $ — $ — $ 184,580 Short-term investments: U.S. government securities $ — $ 34,488 $ — $ 34,488 Corporate bonds — 41,785 — 41,785 Commercial paper — 102,720 — 102,720 Foreign government securities — 4,013 — 4,013 Total short-term investments $ — $ 183,006 $ — $ 183,006 Liabilities: Warrant liability $ — $ — $ 2,829 $ 2,829 Changes in our Level 3 fair value measurements were as follows (in thousands): Warrant Liability Balance, January 31, 2023 $ 2,829 Reclassification of warrants to Accrued expenses and other current liabilities 7,717 Change in fair value (1,954) Balance, October 31, 2023 $ 8,592 Additional information about the Warrant liability, including the fair value inputs, is included in Note 17. Warrants to Purchase Shares of Common Stock . Debt Conversion Liability Balance, January 31, 2023 $ — Initial measurement 6,060 Change in fair value (287) Balance, October 31, 2023 $ 5,773 Additional information about the debt conversion liability, including the fair value inputs, is included in Note 9. Debt . As of October 31, 2023, the net carrying amount of the 2029 Notes, defined in Note 9. Debt , was $356.6 million and the estimated fair value was $260.8 million. The fair value of the 2029 Notes is classified as a Level 3 measurement.

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	9 Months Ended
	Oct. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets	Note 5. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): October 31, 2023 January 31, 2023 Prepaid software subscriptions $ 7,718 $ 7,533 Taxes 4,196 3,860 Contract assets 2,995 1,325 Prepaid insurance 2,165 3,225 Prepaid hosting costs 1,257 871 Deposits 846 1,168 Insurance payments receivable — 2,000 Other 4,377 4,303 Total $ 23,554 $ 24,285

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Note 6. Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): October 31, 2023 January 31, 2023 Software $ 34,639 $ 32,778 Leasehold improvements 14,529 15,254 Computer equipment 11,093 11,780 Furniture and fixtures 4,243 3,793 64,504 63,605 Less: accumulated depreciation and amortization (38,934) (36,446) Total $ 25,570 $ 27,159 The following table summarizes the capitalized internal-use software costs included within the Software line item in the table above (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Internal-use software costs capitalized during the period $ 2,345 $ 1,621 $ 5,043 $ 5,770 October 31, 2023 January 31, 2023 Total capitalized internal-use software, net of accumulated amortization $ 13,921 $ 14,138 During the three and nine months ended October 31, 2023, we recorded an impairment charge of $1.2 million related to certain capitalized software which is included in Research and development in the accompanying unaudited condensed consolidated statements of comprehensive loss. No similar impairment charges were recorded in the three and nine months ended October 31, 2022. The following table summarizes total depreciation and amortization expense related to property and equipment, including amortization of internal-use software, included primarily in General and administrative and Cost of subscription revenue in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Total depreciation and amortization expense $ 2,192 $ 2,646 $ 7,174 $ 7,013

Purchased Intangible Assets and

Purchased Intangible Assets and Goodwill	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Purchased Intangible Assets and Goodwill	Note 7. Purchased Intangible Assets and Goodwill The following tables summarize the purchased intangible asset balances (in thousands): October 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology $ 17,997 $ (9,414) $ 8,583 Customer relationships 5,187 (3,646) 1,541 Trade name 1,709 (1,144) 565 Total $ 24,893 $ (14,204) $ 10,689 January 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology $ 19,571 $ (9,194) $ 10,377 Customer relationships 5,187 (3,225) 1,962 Trade name 1,709 (847) 862 Total $ 26,467 $ (13,266) $ 13,201 During the three and nine months ended October 31, 2023, we recorded an impairment charge of $0.4 million related to intellectual property assets acquired in 2021 which is included in Cost of subscription revenue in the accompanying unaudited condensed consolidated statements of comprehensive loss. No similar impairment charges were recorded in the three and nine months ended October 31, 2022. Purchased intangible assets are being amortized to Cost of subscription revenue in the accompanying unaudited condensed consolidated statements of comprehensive loss on a straight-line basis over their estimated useful lives ranging from three Three Months Ended Nine Months Ended 2023 2022 2023 2022 Purchased intangible assets amortization expense $ 607 $ 586 $ 2,083 $ 1,512 Estimated future amortization expense for purchased intangible assets as of October 31, 2023 was as follows (in thousands): Fiscal year ending: 2024 (remainder of the year) $ 607 2025 2,343 2026 1,874 2027 1,561 2028 1,561 Thereafter 2,743 Total estimated amortization expense $ 10,689 The following table represents the changes to goodwill (in thousands): Goodwill Balance, January 31, 2023 $ 53,991 Effects of foreign currency translation 499 Other 510 Balance, October 31, 2023 $ 55,000

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Oct. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Note 8. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): October 31, 2023 January 31, 2023 Warrant liability $ 8,592 $ 2,829 Debt conversion liability 5,773 — Accrued taxes 4,305 4,088 Accrued hosting and third-party licenses 2,800 4,374 Accrued outside services and consulting 2,138 3,507 Accrued interest 1,492 850 Litigation settlement — 75,000 Accrued contingent consideration — 4,420 Other accrued expenses 2,710 8,610 Total $ 27,810 $ 103,678

Debt

Debt	9 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
Debt	Note 9. Debt 2029 Notes On March 24, 2022 (Initial Closing Date), we issued convertible senior notes (Initial Notes) in the aggregate principal amount of $250.0 million pursuant to an agreement with certain entities affiliated with Silver Lake Alpine II, L.P. (Silver Lake). On September 22, 2023 (Subsequent Closing Date), we issued additional convertible senior notes in the aggregate principal amount of $150.0 million (Additional Notes and together with the Initial Notes, the “2029 Notes”) under the agreement with Silver Lake. The 2029 Notes represent senior unsecured obligations of Zuora. As a condition of the agreement with Silver Lake, we also issued warrants to Silver Lake to acquire up to 7.5 million shares of Class A common stock (Warrants). Refer to Note 17. Warrants to Purchase Shares of Common Stock for more information. The purchase price of the 2029 Notes is 98% of the par value. The 2029 Notes bear interest at a rate of 3.95% per annum, payable quarterly in cash, provided that we have the option to pay interest in kind at 5.50% per annum. The 2029 Notes will mature on March 31, 2029, subject to earlier conversion or repurchase. The 2029 Notes are convertible at Silver Lake’s option into shares of our Class A common stock at an initial conversion rate of 50.0 shares per $1,000 principal amount ($20.00 per share, representing 20.0 million shares of Class A common stock), subject to customary anti-dilution adjustments. Any 2029 Notes that are converted in connection with a "make-whole fundamental change" are subject to an increase in the conversion rate under certain circumstances. The term "make-whole fundamental change" is defined in the indenture for the 2029 Notes, and generally refers to a "fundamental change" including a change in control of Zuora that meets certain specifications or the termination of trading of Zuora's stock on the New York Stock Exchange (or the NASDAQ Global Select Market or the NASDAQ Global Market, or any of their respective successors), in each case subject to certain exceptions and exclusions described in the indenture. On the Initial Closing Date, we concluded that the conversion option contained in the 2029 Notes qualified for a scope exception from derivative accounting and therefore was not bifurcated and accounted for separately from the Initial Notes. On the Subsequent Closing Date, we reassessed the classification of the conversion option and concluded that a portion of the conversion option no longer qualified for equity classification under ASC 815-40 as a result of the issuance of the Additional Notes. Under certain make-whole fundamental change scenarios, we would be required to, at our option, either (i) seek and obtain stockholder approval prior to issuing 20% or more of our outstanding common stock or voting power or (ii) pay cash in lieu of delivering any shares at or above such 20% threshold. As a result of our sequencing policy described in Note 2. Summary of Significant Accounting Policies and Recent Accounting Pronouncements in our Annual Report on Form 10-K, we separated a portion of the conversion option representing approximately 1.4 million shares of Class A common stock issuable upon conversion of the 2029 Notes valued at $6.1 million as of the Subsequent Closing Date from the 2029 Notes and recorded a debt conversion liability at fair value on bifurcation, with an offset to the carrying amount of the 2029 Notes. For further information on our derivative financial instruments policy, refer to Note 2. Summary of Significant Accounting Policies and Recent Accounting Pronouncements in our Annual Report on Form 10-K. We will reassess the classification of the debt conversion liability in future reporting periods to determine if any further change is required. With certain exceptions, upon a "fundamental change" of Zuora, the holders of the 2029 Notes may require that we repurchase all or part of the principal amount of the 2029 Notes at a purchase price equal to the principal amount and accrued but unpaid interest outstanding, plus the total sum of all remaining scheduled interest payments through the remainder of the term of the 2029 Notes, at the 5.50% paid in kind interest rate. At any time on or after the fifth anniversary of the Initial Closing Date, the holders of the 2029 Notes may require that we repurchase all or part of the principal amount of the Notes at a purchase price equal to the principal amount plus accrued interest through the date of repurchase. Upon certain events of default, the 2029 Notes may be declared due and payable (or will automatically become so under certain events of default), at a purchase price equal to the principal amount plus accrued interest through the date of repurchase. We have no right to redeem the 2029 Notes prior to maturity. We incurred an additional $4.1 million of debt issuance costs associated with the issuance of the Additional Notes. The 2029 Notes' debt issuance costs, debt discount, and associated derivatives are being amortized to interest expense using the effective interest rate method over the five year expected life of the 2029 Notes (representing the period from the contract date to the earliest noncontingent put date of May 24, 2027) and reflects an effective interest rate of 7.6%. The carrying value of the 2029 Notes was classified as long-term and consisted of the following (in thousands): October 31, 2023 January 31, 2023 2029 Notes principal $ 400,000 $ 250,000 Unamortized debt issuance costs, debt discount, and associated derivatives (43,355) (39,597) Carrying value $ 356,645 $ 210,403 Interest expense related to the 2029 Notes, included in Interest expense in the accompanying unaudited condensed consolidated statements of comprehensive loss, was as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Contractual interest expense $ 3,111 $ 2,469 $ 8,049 $ 5,953 Amortization of debt discount 2,443 1,967 6,441 4,634 Total interest expense $ 5,554 $ 4,436 $ 14,490 $ 10,587 We used a binomial lattice model to value the bifurcated derivatives contained in the 2029 Notes. ASC 815 does not permit an issuer to account separately for individual derivative terms and features embedded in hybrid financial instruments that require bifurcation and liability classification as derivative financial instruments. Rather, such terms and features must be combined together, and fair-valued as a single, compound embedded derivative. We selected a binomial lattice model to value the compound embedded derivative because we believe this technique is reflective of all significant assumptions that market participants would likely consider in negotiating the transfer of the 2029 Notes. Such assumptions include, among other inputs, stock price volatility, risk-free rates, credit risk assumptions, early redemption and conversion assumptions, and the potential for future adjustment of the conversion rate due to triggering events. Additionally, there are other embedded features contained in the 2029 Notes requiring bifurcation, other than the conversion option, which had no value as of October 31, 2023, the Subsequent Closing Date, and the Initial Closing Date due to management’s estimates of the likelihood of certain events, but that may have value in the future should those estimates change. The debt conversion liability's fair value was measured using a binomial lattice model using the following key inputs: October 31, 2023 September 22, 2023 Fair value of common stock $ 7.41 $ 8.44 Conversion price $ 20.00 $ 20.00 Expected volatility 47.5 % 47.5 % Risk-free interest rate 4.7 % 4.5 % Corporate bond yield 21.4 % 20.5 % Coupon interest rate 3.95 % 3.95 % We recognized a gain on the revaluation of the debt conversion liability, summarized in the table below (in thousands), which is included in Change in fair value of debt conversion and warrant liabilities in the accompanying unaudited condensed consolidated statements of comprehensive loss. Refer to Note 4. Fair Value Measurements for the fair value of the debt conversion liability. Three Months Ended Nine Months Ended 2023 2022 2023 2022 Change in fair value of debt conversion liability $ 287 $ — $ 287 $ — Debt Agreement We have a $30.0 million revolving credit facility under an agreement with Silicon Valley Bank, a division of First-Citizens Bank & Trust. This credit facility matures in October 2025. The interest rate under the credit facility is equal to the prime rate published by the Wall Street Journal minus 1.00%. We had not drawn down any amounts under the facility as of October 31, 2023.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Note 10. Deferred Revenue and Performance Obligations The following table summarizes revenue recognized during the period that was included in the deferred revenue balance at the beginning of each respective period (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Revenue recognized from deferred revenue $ 80,407 $ 75,929 $ 153,729 $ 137,257 As of October 31, 2023, total remaining non-cancellable performance obligations under our subscription contracts with customers was approximately $554.2 million and we expect to recognize revenue on approximately 54% of these remaining performance obligations over the next 12 months. Remaining performance obligations under our professional services contracts as of October 31, 2023 were not material.

Geographical Information

Geographical Information	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Geographical Information	Note 11. Geographical Information Disaggregation of Revenue Revenue by country, based on the customer’s address at the time of sale, was as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 United States $ 70,312 $ 66,902 $ 205,067 $ 191,129 Others 39,537 34,170 115,925 101,917 Total $ 109,849 $ 101,072 $ 320,992 $ 293,046 Percentage of revenue by geographic area: United States 64 % 66 % 64 % 65 % Other 36 % 34 % 36 % 35 % Other than the United States, no individual country exceeded 10% of total revenue for the three and nine months ended October 31, 2023 and 2022. Long-lived assets Long-lived assets, which consist of property and equipment, net, deferred commissions, purchased intangible assets, net and operating lease right-of-use assets by geographic location, are based on the location of the legal entity that owns the asset. As of October 31, 2023 and January 31, 2023, no individual country exceeded 10% of total long-lived assets other than the United States.

Leases

Leases	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Leases	Note 12. Leases We have non-cancelable operating leases for our offices located in the U.S. and abroad. As of October 31, 2023, these leases expire on various dates between 2024 and 2030. Certain lease agreements include one or more options to renew, with renewal terms that can extend the lease up to seven years. We have the right to exercise or forego the lease renewal options. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. The components of our long-term operating leases and related operating lease cost were as follows (in thousands): October 31, 2023 January 31, 2023 Operating lease right-of-use assets $ 25,296 $ 22,768 Operating lease liabilities, current portion $ 7,396 $ 9,240 Operating lease liabilities, net of current portion 38,060 37,924 Total operating lease liabilities $ 45,456 $ 47,164 Three Months Ended Nine Months Ended 2023 2022 2023 2022 Operating lease cost 1 $ 2,117 $ 2,337 $ 6,526 $ 7,589 _____________________________ (1) Includes costs related to our short-term operating leases and is net of sublease income as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Short-term operating lease costs $ 146 $ 118 $ 387 $ 317 Sublease income $ (98) $ — $ (293) $ — The future maturities of long-term operating lease liabilities for each fiscal year were as follows (in thousands): Maturities of Operating Lease Liabilities 2024 (remainder of the year) $ 2,377 2025 8,766 2026 8,694 2027 7,947 2028 7,863 Thereafter 17,484 Total lease payments 53,131 Less imputed interest (7,675) Present value of lease liabilities $ 45,456 Other supplemental information related to our long-term operating leases includes the following (dollars in thousands): October 31, 2023 January 31, 2023 Weighted-average remaining operating lease term 6.1 years 6.7 years Weighted-average operating lease discount rate 5.1 % 4.8 % Three Months Ended Nine Months Ended 2023 2022 2023 2022 Supplemental Cash Flow Information Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases $ 3,143 $ 2,639 $ 10,671 $ 9,461 New right-of-use assets obtained in exchange for lease liabilities: Operating leases obtained $ 427 $ 799 $ 7,400 $ 799

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 13. Commitments and Contingencies Letters of Credit In connection with the execution of certain facility leases, we had bank issued irrevocable letters of credit for $4.5 million as of October 31, 2023 and January 31, 2023. No draws have been made under such letters of credit. Legal Proceedings From time to time, we may be subject to legal proceedings, as well as demands, claims and threatened litigation. The outcomes of legal proceedings and other contingencies are inherently unpredictable, subject to significant uncertainties, and could be material to our operating results and cash flows for a particular period. Regardless of the outcome, litigation can have an adverse impact on our business because of defense and settlement costs, diversion of management resources, and other factors. Other than the matters described below, we are not currently party to any legal proceeding that we believe could have a material adverse effect on our business, operating results, cash flows, or financial condition should such litigation or claim be resolved unfavorably. Securities Class Action Litigation In June 2019, a putative securities class action lawsuit alleging violations of the federal securities laws was filed in the U.S. District Court for the Northern District of California naming Zuora and certain of its officers as defendants, seeking unspecified compensatory damages, fees and costs. In November 2019, the lead plaintiff filed a consolidated amended complaint asserting the same claims, which was captioned Roberts v. Zuora, Inc. , Case No. 3:19-CV-03422 (hereinafter referred to as "Federal Class Action"). In April and May 2020, two putative securities class action lawsuits alleging violations of the federal securities laws were filed and later consolidated in the Superior Court of the State of California, County of San Mateo, naming as defendants Zuora and certain of its current and former officers, its directors and the underwriters of Zuora's initial public offering (IPO), and seeking unspecified damages and other relief. In July 2020, the court entered an order consolidating the two lawsuits, and the lead plaintiffs filed a consolidated amended complaint asserting the same claims. The consolidated class action litigation was captioned Olsen v. Zuora, Inc ., Case No. 20-civ-1918 (hereinafter referred to as "State Class Action"). In March 2023, Zuora entered into an agreement to settle the Federal Class Action without any admission or concession of wrongdoing or liability by Zuora or the named defendants. In June 2023, Zuora reached an agreement to settle the State Class Action without any admission or concession of wrongdoing or liability by Zuora or the named defendants, and agreed to resolve the litigation as part of a combined resolution with the Federal Class Action. In August 2023, the combined settlement of the Federal Class Action and State Class Action received preliminary court approval, and Zuora paid an aggregate of $75.5 million of which $7.2 million was funded by Zuora’s insurance proceeds. The hearing for final approval of the settlement is scheduled for January 2024. Derivative Litigation In September 2019, two stockholder derivative lawsuits were filed and later consolidated in the U.S. District Court for the Northern District of California against certain of Zuora's directors and executive officers and naming Zuora as a nominal defendant. In May and June 2020, two additional stockholder derivative lawsuits were filed and later consolidated in the U.S. District Court for the District of Delaware against certain of Zuora's directors and current and former executive officers. In February and March 2021, two additional stockholder derivative lawsuits were filed and later consolidated in Delaware Chancery Court alleging similar claims based on the same underlying events. These derivative actions alleged claims based on events similar to those in the securities class actions and asserted causes of action against the individual defendants for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and for alleged violation of federal securities laws. In February 2023, Zuora reached an agreement to settle the derivative litigation matters without any admission or concession of wrongdoing or liability by Zuora or the named defendants. In connection with the settlement, Zuora agreed to adopt and implement certain corporate governance modifications and pay $2.0 million for certain plaintiffs' attorney fees, which amount was paid by Zuora's insurance carriers in August 2023. The settlement received final court approval in September 2023. Other Contractual Obligations As of October 31, 2023, we have a contractual obligation to make $6.9 million in purchases of cloud computing services provided by one of our vendors by September 2024.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 14. Income Taxes The following table reflects our income tax provision, pretax loss and effective tax rate for the periods presented (in thousands, except percentages): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Loss before income taxes $ (5,162) $ (36,726) $ (45,963) $ (88,967) Income tax provision 340 308 1,396 1,145 Effective tax rate (6.6) % (0.8) % (3.0) % (1.3) %

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Stockholders' Equity	Note 15. Stockholders’ Equity Preferred Stock As of October 31, 2023, Zuora had authorized 10 million shares of preferred stock, each with a par value of $0.0001 per share. As of October 31, 2023, no shares of preferred stock were issued and outstanding. Common Stock Prior to Zuora's IPO, which was effective in April 2018, all shares of common stock then outstanding were reclassified into Class B common stock. Shares offered and sold in the IPO consisted of newly authorized shares of Class A common stock. Holders of Class A and Class B common stock are entitled to one vote per share and ten votes per share, respectively, and the shares of Class A common stock and Class B common stock are identical, except for voting rights and the right to convert Class B common stock to Class A common stock. As of October 31, 2023, Zuora had authorized 500 million shares of Class A common stock and 500 million shares of Class B common stock, each with a par value of $0.0001 per share. As of October 31, 2023, 135.0 million shares of Class A common stock and 8.1 million shares of Class B common stock were issued and outstanding. Accumulated Other Comprehensive Loss Components of accumulated other comprehensive loss were as follows (in thousands): Foreign Currency Translation Adjustment Unrealized Loss on Available-for-Sale Securities Total Balance, January 31, 2023 $ (343) $ (576) $ (919) Foreign currency translation adjustment (1,383) — (1,383) Unrealized gain on available-for-sale securities — 494 494 Balance, October 31, 2023 $ (1,726) $ (82) $ (1,808) There were no material reclassifications out of accumulated other comprehensive loss during the three and nine months ended October 31, 2023. Additionally, there was no material tax impact on the amounts presented.

Employee Stock Plans

Employee Stock Plans	9 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Employee Stock Plans	Note 16. Employee Stock Plans Equity Incentive Plans Our 2018 Equity Incentive Plan (2018 Plan) authorizes the award of stock options, restricted stock awards, stock appreciation rights, restricted stock units (RSUs), performance awards, and stock bonuses. As of October 31, 2023, approximately 26.8 million shares of Class A common stock were reserved and available for issuance under the 2018 Plan. In addition, as of October 31, 2023, 4.0 million stock options and RSUs exercisable or settleable for Class B common stock were outstanding in the aggregate under our 2006 Stock Plan (2006 Plan) and 2015 Equity Incentive Plan (2015 Plan), which plans were terminated in May 2015 and April 2018, respectively. The 2006 Plan and 2015 Plan continue to govern outstanding equity awards granted thereunder. Stock Options The following tables summarize stock option activity and related information (in thousands, except weighted-average exercise price, weighted-average grant date fair value and average remaining contractual term): Shares Weighted-Average Average Aggregate Balance, January 31, 2023 7,761 $ 9.28 5.0 $ 14,505 Exercised (215) 4.57 Cancelled (775) 13.28 Forfeited (183) 12.67 Balance, October 31, 2023 6,588 8.87 4.0 12,205 Exercisable as of October 31, 2023 3,017 3.36 1.7 12,205 Vested and expected to vest as of October 31, 2023 6,563 $ 8.85 3.9 $ 12,205 Three Months Ended Nine Months Ended 2023 1 2022 1 2023 1 2022 Weighted-average grant date fair value per share of options granted during each respective period $ — $ — $ — $ 5.54 Aggregate intrinsic value of options exercised during each respective period $ 73 $ 356 $ 1,104 $ 2,386 _________________________________ (1) No stock options were granted during the three and nine months ended October 31, 2023, or the three months ended October 31, 2022. RSUs The following table summarizes RSU activity and related information (in thousands, except weighted-average grant date fair value): Number of RSUs Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2023 12,504 $ 12.98 Granted 7,785 8.12 Vested (6,224) 11.87 Forfeited (1,398) 12.92 Balance, October 31, 2023 12,667 $ 10.54 Performance Stock Units (PSUs) In March 2022, July 2023, and September 2023, we granted PSUs to certain executives under our 2018 Plan. Each grant is divided into two or three tranches, each tranche having pre-established performance targets that if met, as determined quarterly by our Compensation Committee, would result in the shares attributable to such tranche being earned, subject to a service-based vesting condition. The shares attributable to unearned tranches will be forfeited on January 31, 2025 if the applicable performance criteria for such tranches are not met. Stock-based compensation expense is recognized if it is probable the performance targets (for each respective tranche) will be met during the performance period. As we previously disclosed in our Form 10-Q for the three months ended April 30, 2023 filed with the SEC on June 1, 2023, we modified the performance targets associated with the PSUs that were granted in March 2022. This resulted in $9.6 million of incremental compensation expense that is being recognized over the remaining vesting periods of the awards. The following table summarizes PSU activity and related information (in thousands, except weighted-average grant date fair value): Number of PSUs Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2023 2,905 $ 15.21 Granted 420 10.24 Vested (240) 15.21 Forfeited (525) 15.21 Balance, October 31, 2023 2,560 $ 14.40 2018 Employee Stock Purchase Plan Our 2018 Employee Stock Purchase Plan (ESPP) is broadly available to our employees in the United States and certain other countries in which we operate. A total of 4.9 million shares of Class A common stock were reserved and available for issuance under the ESPP as of October 31, 2023. The ESPP provides for 24-month offering periods beginning June 15 and December 15 of each year, and each offering period contains four six-month purchase periods. On each purchase date, ESPP participants will purchase shares of our Class A common stock at a price per share equal to 85% of the lesser of (1) the fair market value of the Class A common stock on the offering date or (2) the fair market value of the Class A common stock on the purchase date. We estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions: Three and Nine Months Ended October 31, 2023 Three and Nine Months Ended October 31, 2022 Fair value of common stock $ 11.55 $ 8.91 Expected volatility 37.1% - 45.7% 44.4% - 52.3% Expected term (in years) 0.5 - 2.0 0.5 - 2.0 Risk-free interest rate 3.0% - 4.8% 2.3% -3.2% Expected dividend yield — % — % Stock-Based Compensation Expense Stock-based compensation expense was recorded in the following cost and expense categories in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Cost of subscription revenue $ 2,350 $ 2,437 $ 6,889 $ 6,517 Cost of professional services revenue 2,747 3,479 8,997 10,186 Research and development 7,165 7,536 20,661 20,967 Sales and marketing 8,191 10,188 24,857 27,603 General and administrative 5,648 5,367 16,569 14,772 Total stock-based compensation expense $ 26,101 $ 29,007 $ 77,973 $ 80,045 As of October 31, 2023, unrecognized compensation costs related to unvested equity awards and the weighted-average remaining period over which those costs are expected to be recognized were as follows (dollars in thousands): Stock Options RSUs PSUs ESPP Unrecognized compensation costs $ 2,197 $ 114,874 $ 21,049 $ 5,722 Weighted-average remaining recognition period 1.2 years 1.9 years 1.3 years 0.8 years

Warrants to Purchase Shares of

Warrants to Purchase Shares of Common Stock	9 Months Ended
	Oct. 31, 2023
Other Liabilities Disclosure [Abstract]
Warrants to Purchase Shares of Common Stock	Note 17. Warrants to Purchase Shares of Common Stock In connection with the issuance of the 2029 Notes (discussed Note 9. Debt ), we issued to Silver Lake Warrants to acquire up to 7.5 million shares of Class A common stock, exercisable for a period of approximately seven years from the Initial Closing Date, and of which (i) Warrants to purchase up to 2.5 million shares of Class A common stock are exercisable at $20.00 per share, (ii) Warrants to purchase up to 2.5 million shares of Class A common stock are exercisable at $22.00 per share, and (iii) Warrants to purchase up to 2.5 million shares of Class A common stock are exercisable at $24.00 per share. In addition, Silver Lake can elect to exercise the Warrants on a net-exercise basis. In the event of a "make-whole fundamental change" (as defined in the Form of Warrant, which has a similar definition as in the indenture, described above in Note. 9 Debt ), the number of shares issuable by Zuora upon exercise of the Warrants may be increased, and the exercise price for the Warrants adjusted. As of October 31, 2023, all 7.5 million Warrants were outstanding. On the Initial Closing Date, we classified a portion of the Warrants as a current liability due to certain settlement provisions in the Warrants. Under certain make-whole fundamental change scenarios, we would be required to, at our option, either (i) obtain shareholder approval prior to issuing 20% or more of our outstanding common stock or (ii) pay cash in lieu of delivering any shares at or above such 20% threshold. As a result, we concluded that approximately 2.8 million Warrants valued at $12.0 million as of the Initial Closing Date did not qualify for equity classification under ASC 815-40, pursuant to our sequencing policy. As a result of the issuance of the Additional Notes, we reassessed the classification of the Warrants and concluded that no Warrants qualified for equity classification under ASC 815-40. Accordingly, we reclassified 4.7 million Warrants valued at $7.7 million from equity to liability as of the Subsequent Closing Date. We will reassess the classification of the Warrant liability in future reporting periods to determine if any change is required. The liability-classified warrants' fair value was measured using the Black-Scholes option pricing model using the following inputs: October 31, 2023 September 22, 2023 January 31, 2023 Fair value of common stock 1 $ 7.41 $ 8.44 $ 7.24 Exercise price $20.00 - $24.00 $20.00 - $24.00 $22.00 - $24.00 Expected volatility 42.4 % 42.2 % 41.2 % Expected term (in years) 5.4 5.5 6.2 Risk-free interest rate 4.8 % 4.6 % 3.6 % Expected dividend yield — — — ______________ (1) The fair value of common stock as of January 31, 2023 was adjusted to reflect certain restrictions on the Warrants. Such restrictions expired in September 2023. We recognized gains on the revaluation of the liability-classified Warrants, summarized in the table below (in thousands), which are included in Change in fair value of debt conversion and warrant liabilities in the accompanying unaudited condensed consolidated statements of comprehensive loss. Refer to Note 4. Fair Value Measurements for the fair value of the liability-classified Warrants. Three Months Ended Nine Months Ended 2023 2022 2023 2022 Change in fair value of warrant liability $ 6,710 $ 452 $ 1,954 $ 9,348

Net Loss Per Share

Net Loss Per Share	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	Note 18. Net Loss Per Share The following table presents the calculation of basic and diluted net loss per share for the periods presented (in thousands, except per share data): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Numerator: Net loss $ (5,502) $ (37,034) $ (47,359) $ (90,112) Denominator: Weighted-average common shares outstanding, basic and diluted 141,488 132,579 138,789 130,461 Net loss per share, basic and diluted $ (0.04) $ (0.28) $ (0.34) $ (0.69) Since we were in a net loss position for all periods presented, basic net loss per share attributable to common stockholders is the same as diluted net loss per share, as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): October 31, 2023 2022 2029 Notes conversion 20,000 12,500 Unvested RSUs issued and outstanding 12,667 14,234 Warrants 7,500 7,500 Issued and outstanding stock options 6,588 7,875 Unvested PSUs issued and outstanding 2,560 2,905 Shares committed under ESPP 598 439 Total 49,913 45,453

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Pay vs Performance Disclosure
Net loss	$ (5,502)	$ (37,034)	$ (47,359)	$ (90,112)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)	9 Months Ended
	Oct. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements, which include the accounts of Zuora and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States (GAAP) and applicable rules and regulations of the SEC regarding interim financial reporting. All intercompany balances and transactions have been eliminated in consolidation. The unaudited condensed consolidated balance sheet as of January 31, 2023 included herein was derived from the audited financial statements as of that date, but does not include all disclosures including certain notes required by GAAP on an annual reporting basis. The unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets, statements of comprehensive loss, statements of cash flows and statements of stockholders' equity for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2024 or any future period. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023.
Use of Estimates	Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the unaudited condensed consolidated financial statements, as well as reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates. Our most significant estimates and assumptions are related to revenue recognition with respect to the determination of the relative standalone selling prices for our services; the expected period of benefit over which deferred commissions are amortized; valuation of stock-based awards and our convertible senior notes and warrants; estimates of allowance for credit losses; estimates of the fair value of goodwill and long-lived assets when evaluating for impairments and for assets acquired from acquisitions; useful lives of intangibles and other long-lived assets; and the valuation of deferred income tax assets and contingencies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results may differ materially from these estimates under different assumptions or conditions.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Oct. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Cost, Unrealized Gains and Losses and Estimated Fair Value of Short-term Investments	The amortized costs, unrealized gains and losses and estimated fair values of our short-term investments were as follows (in thousands): October 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. government securities $ 18,841 $ — $ (23) $ 18,818 Corporate bonds 8,095 — (11) 8,084 Commercial paper 52,051 — (48) 52,003 Total short-term investments $ 78,987 $ — $ (82) $ 78,905 January 31, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value U.S. government securities $ 34,865 $ — $ (377) $ 34,488 Corporate bonds 41,974 — (189) 41,785 Commercial paper 102,720 — — 102,720 Foreign government securities 4,023 — (10) 4,013 Total short-term investments $ 183,582 $ — $ (576) $ 183,006

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 31, 2023
Fair Value Disclosures [Abstract]
Summary of Fair Value Hierarchy for Financial Assets Measured on a Recurring Basis	The following tables summarize our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis (in thousands): October 31, 2023 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 355,951 $ — $ — $ 355,951 Treasury bills 4,959 — — 4,959 Total cash equivalents $ 360,910 $ — $ — $ 360,910 Short-term investments: U.S. government securities $ — $ 18,818 $ — $ 18,818 Corporate bonds — 8,084 — 8,084 Commercial paper — 52,003 — 52,003 Total short-term investments $ — $ 78,905 $ — $ 78,905 Liabilities: Warrant liability $ — $ — $ 8,592 $ 8,592 Debt conversion liability — — 5,773 5,773 Total liabilities $ — $ — $ 14,365 $ 14,365 January 31, 2023 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 184,580 $ — $ — $ 184,580 Short-term investments: U.S. government securities $ — $ 34,488 $ — $ 34,488 Corporate bonds — 41,785 — 41,785 Commercial paper — 102,720 — 102,720 Foreign government securities — 4,013 — 4,013 Total short-term investments $ — $ 183,006 $ — $ 183,006 Liabilities: Warrant liability $ — $ — $ 2,829 $ 2,829
Schedule of Changes in Level 3 Fair Value Measurements	Changes in our Level 3 fair value measurements were as follows (in thousands): Warrant Liability Balance, January 31, 2023 $ 2,829 Reclassification of warrants to Accrued expenses and other current liabilities 7,717 Change in fair value (1,954) Balance, October 31, 2023 $ 8,592 Debt Conversion Liability Balance, January 31, 2023 $ — Initial measurement 6,060 Change in fair value (287) Balance, October 31, 2023 $ 5,773

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	9 Months Ended
	Oct. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): October 31, 2023 January 31, 2023 Prepaid software subscriptions $ 7,718 $ 7,533 Taxes 4,196 3,860 Contract assets 2,995 1,325 Prepaid insurance 2,165 3,225 Prepaid hosting costs 1,257 871 Deposits 846 1,168 Insurance payments receivable — 2,000 Other 4,377 4,303 Total $ 23,554 $ 24,285

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): October 31, 2023 January 31, 2023 Software $ 34,639 $ 32,778 Leasehold improvements 14,529 15,254 Computer equipment 11,093 11,780 Furniture and fixtures 4,243 3,793 64,504 63,605 Less: accumulated depreciation and amortization (38,934) (36,446) Total $ 25,570 $ 27,159 The following table summarizes the capitalized internal-use software costs included within the Software line item in the table above (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Internal-use software costs capitalized during the period $ 2,345 $ 1,621 $ 5,043 $ 5,770 October 31, 2023 January 31, 2023 Total capitalized internal-use software, net of accumulated amortization $ 13,921 $ 14,138 The following table summarizes total depreciation and amortization expense related to property and equipment, including amortization of internal-use software, included primarily in General and administrative and Cost of subscription revenue in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Total depreciation and amortization expense $ 2,192 $ 2,646 $ 7,174 $ 7,013

Purchased Intangible Assets a_2

Purchased Intangible Assets and Goodwill (Tables)	9 Months Ended
	Oct. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Purchased Intangible Assets	The following tables summarize the purchased intangible asset balances (in thousands): October 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology $ 17,997 $ (9,414) $ 8,583 Customer relationships 5,187 (3,646) 1,541 Trade name 1,709 (1,144) 565 Total $ 24,893 $ (14,204) $ 10,689 January 31, 2023 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Developed technology $ 19,571 $ (9,194) $ 10,377 Customer relationships 5,187 (3,225) 1,962 Trade name 1,709 (847) 862 Total $ 26,467 $ (13,266) $ 13,201
Schedule of Amortization Expense Related to Purchased Intangible Assets	The following table summarizes amortization expense recognized on purchased intangible assets during the periods indicated (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Purchased intangible assets amortization expense $ 607 $ 586 $ 2,083 $ 1,512
Schedule of Estimated Future Amortization Expense	Estimated future amortization expense for purchased intangible assets as of October 31, 2023 was as follows (in thousands): Fiscal year ending: 2024 (remainder of the year) $ 607 2025 2,343 2026 1,874 2027 1,561 2028 1,561 Thereafter 2,743 Total estimated amortization expense $ 10,689
Schedule of Goodwill	The following table represents the changes to goodwill (in thousands): Goodwill Balance, January 31, 2023 $ 53,991 Effects of foreign currency translation 499 Other 510 Balance, October 31, 2023 $ 55,000

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Oct. 31, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): October 31, 2023 January 31, 2023 Warrant liability $ 8,592 $ 2,829 Debt conversion liability 5,773 — Accrued taxes 4,305 4,088 Accrued hosting and third-party licenses 2,800 4,374 Accrued outside services and consulting 2,138 3,507 Accrued interest 1,492 850 Litigation settlement — 75,000 Accrued contingent consideration — 4,420 Other accrued expenses 2,710 8,610 Total $ 27,810 $ 103,678

Debt (Tables)

Debt (Tables)	9 Months Ended
	Oct. 31, 2023
Debt Disclosure [Abstract]
Schedule of Carry Value of Long-term Debt	The carrying value of the 2029 Notes was classified as long-term and consisted of the following (in thousands): October 31, 2023 January 31, 2023 2029 Notes principal $ 400,000 $ 250,000 Unamortized debt issuance costs, debt discount, and associated derivatives (43,355) (39,597) Carrying value $ 356,645 $ 210,403
Schedule of Interest Expense	Interest expense related to the 2029 Notes, included in Interest expense in the accompanying unaudited condensed consolidated statements of comprehensive loss, was as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Contractual interest expense $ 3,111 $ 2,469 $ 8,049 $ 5,953 Amortization of debt discount 2,443 1,967 6,441 4,634 Total interest expense $ 5,554 $ 4,436 $ 14,490 $ 10,587
Summary of Fair Value Measurements Inputs and Valuation Techniques	The debt conversion liability's fair value was measured using a binomial lattice model using the following key inputs: October 31, 2023 September 22, 2023 Fair value of common stock $ 7.41 $ 8.44 Conversion price $ 20.00 $ 20.00 Expected volatility 47.5 % 47.5 % Risk-free interest rate 4.7 % 4.5 % Corporate bond yield 21.4 % 20.5 % Coupon interest rate 3.95 % 3.95 % The liability-classified warrants' fair value was measured using the Black-Scholes option pricing model using the following inputs: October 31, 2023 September 22, 2023 January 31, 2023 Fair value of common stock 1 $ 7.41 $ 8.44 $ 7.24 Exercise price $20.00 - $24.00 $20.00 - $24.00 $22.00 - $24.00 Expected volatility 42.4 % 42.2 % 41.2 % Expected term (in years) 5.4 5.5 6.2 Risk-free interest rate 4.8 % 4.6 % 3.6 % Expected dividend yield — — — ______________ (1) The fair value of common stock as of January 31, 2023 was adjusted to reflect certain restrictions on the Warrants. Such restrictions expired in September 2023.
Schedule of Derivative Liabilities at Fair Value	We recognized a gain on the revaluation of the debt conversion liability, summarized in the table below (in thousands), which is included in Change in fair value of debt conversion and warrant liabilities in the accompanying unaudited condensed consolidated statements of comprehensive loss. Refer to Note 4. Fair Value Measurements for the fair value of the debt conversion liability. Three Months Ended Nine Months Ended 2023 2022 2023 2022 Change in fair value of debt conversion liability $ 287 $ — $ 287 $ —

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Tables)	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Revenue Recognized that was Previously Included In Deferred Revenue	The following table summarizes revenue recognized during the period that was included in the deferred revenue balance at the beginning of each respective period (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Revenue recognized from deferred revenue $ 80,407 $ 75,929 $ 153,729 $ 137,257

Geographical Information (Table

Geographical Information (Tables)	9 Months Ended
	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Country Based on Customer Address at Time of Sale	Revenue by country, based on the customer’s address at the time of sale, was as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 United States $ 70,312 $ 66,902 $ 205,067 $ 191,129 Others 39,537 34,170 115,925 101,917 Total $ 109,849 $ 101,072 $ 320,992 $ 293,046 Percentage of revenue by geographic area: United States 64 % 66 % 64 % 65 % Other 36 % 34 % 36 % 35 %

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2023
Leases [Abstract]
Schedule of Components of Leases and Lease Costs	The components of our long-term operating leases and related operating lease cost were as follows (in thousands): October 31, 2023 January 31, 2023 Operating lease right-of-use assets $ 25,296 $ 22,768 Operating lease liabilities, current portion $ 7,396 $ 9,240 Operating lease liabilities, net of current portion 38,060 37,924 Total operating lease liabilities $ 45,456 $ 47,164 Three Months Ended Nine Months Ended 2023 2022 2023 2022 Operating lease cost 1 $ 2,117 $ 2,337 $ 6,526 $ 7,589 _____________________________ (1) Includes costs related to our short-term operating leases and is net of sublease income as follows (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Short-term operating lease costs $ 146 $ 118 $ 387 $ 317 Sublease income $ (98) $ — $ (293) $ —
Schedule of Maturities of Operating Lease Liabilities	The future maturities of long-term operating lease liabilities for each fiscal year were as follows (in thousands): Maturities of Operating Lease Liabilities 2024 (remainder of the year) $ 2,377 2025 8,766 2026 8,694 2027 7,947 2028 7,863 Thereafter 17,484 Total lease payments 53,131 Less imputed interest (7,675) Present value of lease liabilities $ 45,456
Schedule of Supplemental Operating Lease Information	Other supplemental information related to our long-term operating leases includes the following (dollars in thousands): October 31, 2023 January 31, 2023 Weighted-average remaining operating lease term 6.1 years 6.7 years Weighted-average operating lease discount rate 5.1 % 4.8 % Three Months Ended Nine Months Ended 2023 2022 2023 2022 Supplemental Cash Flow Information Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases $ 3,143 $ 2,639 $ 10,671 $ 9,461 New right-of-use assets obtained in exchange for lease liabilities: Operating leases obtained $ 427 $ 799 $ 7,400 $ 799

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Income Tax Provision, Pretax Loss, and Effective Tax Rate	The following table reflects our income tax provision, pretax loss and effective tax rate for the periods presented (in thousands, except percentages): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Loss before income taxes $ (5,162) $ (36,726) $ (45,963) $ (88,967) Income tax provision 340 308 1,396 1,145 Effective tax rate (6.6) % (0.8) % (3.0) % (1.3) %

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Oct. 31, 2023
Equity [Abstract]
Schedule of Components of Accumulated Other Comprehensive Income	Components of accumulated other comprehensive loss were as follows (in thousands): Foreign Currency Translation Adjustment Unrealized Loss on Available-for-Sale Securities Total Balance, January 31, 2023 $ (343) $ (576) $ (919) Foreign currency translation adjustment (1,383) — (1,383) Unrealized gain on available-for-sale securities — 494 494 Balance, October 31, 2023 $ (1,726) $ (82) $ (1,808)

Employee Stock Plans (Tables)

Employee Stock Plans (Tables)	9 Months Ended
	Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	The following tables summarize stock option activity and related information (in thousands, except weighted-average exercise price, weighted-average grant date fair value and average remaining contractual term): Shares Weighted-Average Average Aggregate Balance, January 31, 2023 7,761 $ 9.28 5.0 $ 14,505 Exercised (215) 4.57 Cancelled (775) 13.28 Forfeited (183) 12.67 Balance, October 31, 2023 6,588 8.87 4.0 12,205 Exercisable as of October 31, 2023 3,017 3.36 1.7 12,205 Vested and expected to vest as of October 31, 2023 6,563 $ 8.85 3.9 $ 12,205
Schedule of Stock Option Grant Date Fair Value and Intrinsic Value of Options Exercised	Three Months Ended Nine Months Ended 2023 1 2022 1 2023 1 2022 Weighted-average grant date fair value per share of options granted during each respective period $ — $ — $ — $ 5.54 Aggregate intrinsic value of options exercised during each respective period $ 73 $ 356 $ 1,104 $ 2,386 _________________________________ (1) No stock options were granted during the three and nine months ended October 31, 2023, or the three months ended October 31, 2022.
Schedule of RSU Activity	The following table summarizes RSU activity and related information (in thousands, except weighted-average grant date fair value): Number of RSUs Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2023 12,504 $ 12.98 Granted 7,785 8.12 Vested (6,224) 11.87 Forfeited (1,398) 12.92 Balance, October 31, 2023 12,667 $ 10.54
Schedule of PSU Activity	The following table summarizes PSU activity and related information (in thousands, except weighted-average grant date fair value): Number of PSUs Outstanding Weighted-Average Grant Date Fair Value Balance, January 31, 2023 2,905 $ 15.21 Granted 420 10.24 Vested (240) 15.21 Forfeited (525) 15.21 Balance, October 31, 2023 2,560 $ 14.40
Schedule of Valuation Assumptions for Estimated Fair Value of Employee Stock Purchase Plan	We estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions: Three and Nine Months Ended October 31, 2023 Three and Nine Months Ended October 31, 2022 Fair value of common stock $ 11.55 $ 8.91 Expected volatility 37.1% - 45.7% 44.4% - 52.3% Expected term (in years) 0.5 - 2.0 0.5 - 2.0 Risk-free interest rate 3.0% - 4.8% 2.3% -3.2% Expected dividend yield — % — %
Schedule of Stock-Based Compensation Expense	Stock-based compensation expense was recorded in the following cost and expense categories in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Cost of subscription revenue $ 2,350 $ 2,437 $ 6,889 $ 6,517 Cost of professional services revenue 2,747 3,479 8,997 10,186 Research and development 7,165 7,536 20,661 20,967 Sales and marketing 8,191 10,188 24,857 27,603 General and administrative 5,648 5,367 16,569 14,772 Total stock-based compensation expense $ 26,101 $ 29,007 $ 77,973 $ 80,045
Schedule of Unrecognized Compensation Costs Related to Unvested Equity Awards	As of October 31, 2023, unrecognized compensation costs related to unvested equity awards and the weighted-average remaining period over which those costs are expected to be recognized were as follows (dollars in thousands): Stock Options RSUs PSUs ESPP Unrecognized compensation costs $ 2,197 $ 114,874 $ 21,049 $ 5,722 Weighted-average remaining recognition period 1.2 years 1.9 years 1.3 years 0.8 years

Warrants to Purchase Shares o_2

Warrants to Purchase Shares of Common Stock (Tables)	9 Months Ended
	Oct. 31, 2023
Other Liabilities Disclosure [Abstract]
Summary of Fair Value Measurements Inputs and Valuation Techniques	The debt conversion liability's fair value was measured using a binomial lattice model using the following key inputs: October 31, 2023 September 22, 2023 Fair value of common stock $ 7.41 $ 8.44 Conversion price $ 20.00 $ 20.00 Expected volatility 47.5 % 47.5 % Risk-free interest rate 4.7 % 4.5 % Corporate bond yield 21.4 % 20.5 % Coupon interest rate 3.95 % 3.95 % The liability-classified warrants' fair value was measured using the Black-Scholes option pricing model using the following inputs: October 31, 2023 September 22, 2023 January 31, 2023 Fair value of common stock 1 $ 7.41 $ 8.44 $ 7.24 Exercise price $20.00 - $24.00 $20.00 - $24.00 $22.00 - $24.00 Expected volatility 42.4 % 42.2 % 41.2 % Expected term (in years) 5.4 5.5 6.2 Risk-free interest rate 4.8 % 4.6 % 3.6 % Expected dividend yield — — — ______________ (1) The fair value of common stock as of January 31, 2023 was adjusted to reflect certain restrictions on the Warrants. Such restrictions expired in September 2023.
Summary of Realized Losses and Gain on the Revaluation of the Liability-Classified Warrants	Three Months Ended Nine Months Ended 2023 2022 2023 2022 Change in fair value of warrant liability $ 6,710 $ 452 $ 1,954 $ 9,348

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	9 Months Ended
	Oct. 31, 2023
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share for the periods presented (in thousands, except per share data): Three Months Ended Nine Months Ended 2023 2022 2023 2022 Numerator: Net loss $ (5,502) $ (37,034) $ (47,359) $ (90,112) Denominator: Weighted-average common shares outstanding, basic and diluted 141,488 132,579 138,789 130,461 Net loss per share, basic and diluted $ (0.04) $ (0.28) $ (0.34) $ (0.69)
Schedule of Potential Dilutive Securities Not Included in the Diluted Per Share Calculations	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands): October 31, 2023 2022 2029 Notes conversion 20,000 12,500 Unvested RSUs issued and outstanding 12,667 14,234 Warrants 7,500 7,500 Issued and outstanding stock options 6,588 7,875 Unvested PSUs issued and outstanding 2,560 2,905 Shares committed under ESPP 598 439 Total 49,913 45,453

Investments - Amortized Cost to

Investments - Amortized Cost to Fair Value (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 78,987	$ 183,582
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(82)	(576)
Fair Value	78,905	183,006
U.S. government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	18,841	34,865
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(23)	(377)
Fair Value	18,818	34,488
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	8,095	41,974
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(11)	(189)
Fair Value	8,084	41,785
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	52,051	102,720
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(48)	0
Fair Value	$ 52,003	102,720
Foreign government securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		4,023
Gross Unrealized Gains		0
Gross Unrealized Losses		(10)
Fair Value		$ 4,013

Investments - Narrative (Detail

Investments - Narrative (Details)	Oct. 31, 2023
Maximum
Debt Securities, Available-for-sale [Line Items]
Securities stated effective maturities (in years)	1 year

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy for Financial Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Short-term investments:
Short-term investments	$ 78,905	$ 183,006
U.S. government securities
Short-term investments:
Short-term investments	18,818	34,488
Corporate bonds
Short-term investments:
Short-term investments	8,084	41,785
Commercial paper
Short-term investments:
Short-term investments	52,003	102,720
Foreign government securities
Short-term investments:
Short-term investments		4,013
Recurring
Cash equivalents:
Cash equivalents	360,910
Short-term investments:
Short-term investments	78,905	183,006
Liabilities:
Total liabilities	14,365
Recurring | Money market funds
Cash equivalents:
Cash equivalents	355,951	184,580
Recurring | Treasury bills
Cash equivalents:
Cash equivalents	4,959
Recurring | U.S. government securities
Short-term investments:
Short-term investments	18,818	34,488
Recurring | Corporate bonds
Short-term investments:
Short-term investments	8,084	41,785
Recurring | Commercial paper
Short-term investments:
Short-term investments	52,003	102,720
Recurring | Foreign government securities
Short-term investments:
Short-term investments		4,013
Recurring | Warrant liability
Liabilities:
Total liabilities	8,592	2,829
Recurring | Debt conversion liability
Liabilities:
Total liabilities	5,773
Recurring | Level 1
Cash equivalents:
Cash equivalents	360,910
Short-term investments:
Short-term investments	0	0
Liabilities:
Total liabilities	0
Recurring | Level 1 | Money market funds
Cash equivalents:
Cash equivalents	355,951	184,580
Recurring | Level 1 | Treasury bills
Cash equivalents:
Cash equivalents	4,959
Recurring | Level 1 | U.S. government securities
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Corporate bonds
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Commercial paper
Short-term investments:
Short-term investments	0	0
Recurring | Level 1 | Foreign government securities
Short-term investments:
Short-term investments		0
Recurring | Level 1 | Warrant liability
Liabilities:
Total liabilities	0	0
Recurring | Level 1 | Debt conversion liability
Liabilities:
Total liabilities	0
Recurring | Level 2
Cash equivalents:
Cash equivalents	0
Short-term investments:
Short-term investments	78,905	183,006
Liabilities:
Total liabilities	0
Recurring | Level 2 | Money market funds
Cash equivalents:
Cash equivalents	0	0
Recurring | Level 2 | Treasury bills
Cash equivalents:
Cash equivalents	0
Recurring | Level 2 | U.S. government securities
Short-term investments:
Short-term investments	18,818	34,488
Recurring | Level 2 | Corporate bonds
Short-term investments:
Short-term investments	8,084	41,785
Recurring | Level 2 | Commercial paper
Short-term investments:
Short-term investments	52,003	102,720
Recurring | Level 2 | Foreign government securities
Short-term investments:
Short-term investments		4,013
Recurring | Level 2 | Warrant liability
Liabilities:
Total liabilities	0	0
Recurring | Level 2 | Debt conversion liability
Liabilities:
Total liabilities	0
Recurring | Level 3
Cash equivalents:
Cash equivalents	0
Short-term investments:
Short-term investments	0	0
Liabilities:
Total liabilities	14,365
Recurring | Level 3 | Money market funds
Cash equivalents:
Cash equivalents	0	0
Recurring | Level 3 | Treasury bills
Cash equivalents:
Cash equivalents	0
Recurring | Level 3 | U.S. government securities
Short-term investments:
Short-term investments	0	0
Recurring | Level 3 | Corporate bonds
Short-term investments:
Short-term investments	0	0
Recurring | Level 3 | Commercial paper
Short-term investments:
Short-term investments	0	0
Recurring | Level 3 | Foreign government securities
Short-term investments:
Short-term investments		0
Recurring | Level 3 | Warrant liability
Liabilities:
Total liabilities	8,592	$ 2,829
Recurring | Level 3 | Debt conversion liability
Liabilities:
Total liabilities	$ 5,773

Fair Value Measurements - Chang

Fair Value Measurements - Changes in Level 3 Fair Value Measurements (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Warrant Liability
Changes in Level 3 Fair Value Measurements
Beginning balance	$ 2,829
Reclassification of warrants to Accrued expenses and other current liabilities	7,717
Change in fair value	(1,954)
Ending balance	8,592
Debt Conversion Liability
Changes in Level 3 Fair Value Measurements
Beginning balance	0
Initial measurement	6,060
Change in fair value	(287)
Ending balance	$ 5,773

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Convertible debt	$ 260,800
Initial Notes | Convertible Senior Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance on term loan	$ 356,645	$ 210,403

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Prepaid expenses and other current assets
Prepaid software subscriptions	$ 7,718	$ 7,533
Taxes	4,196	3,860
Contract assets	2,995	1,325
Prepaid insurance	2,165	3,225
Prepaid hosting costs	1,257	871
Deposits	846	1,168
Insurance payments receivable	0	2,000
Other	4,377	4,303
Total	$ 23,554	$ 24,285

Property and Equipment, Net - S

Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Property and Equipment [Line Items]
Property and equipment, gross	$ 64,504	$ 63,605
Less: accumulated depreciation and amortization	(38,934)	(36,446)
Total	25,570	27,159
Software
Property and Equipment [Line Items]
Property and equipment, gross	34,639	32,778
Leasehold improvements
Property and Equipment [Line Items]
Property and equipment, gross	14,529	15,254
Computer equipment
Property and Equipment [Line Items]
Property and equipment, gross	11,093	11,780
Furniture and fixtures
Property and Equipment [Line Items]
Property and equipment, gross	$ 4,243	$ 3,793

Property and Equipment, Net - C

Property and Equipment, Net - Capitalized Internal-use Software Costs (Details) - Internal-use software - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Property and Equipment [Line Items]
Internal-use software costs capitalized during the period	$ 2,345	$ 1,621	$ 5,043	$ 5,770
Total capitalized internal-use software, net of accumulated amortization	$ 13,921		$ 13,921		$ 14,138

Property and Equipment, Net - N

Property and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Property, Plant and Equipment [Abstract]
Impairment charge of capitalized software	$ 1.2	$ 0	$ 1.2	$ 0

Property and Equipment, Net - D

Property and Equipment, Net - Depreciation and Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Property, Plant and Equipment [Abstract]
Total depreciation and amortization expense	$ 2,192	$ 2,646	$ 7,174	$ 7,013

Purchased Intangible Assets a_3

Purchased Intangible Assets and Goodwill - Summary of Purchased Intangible Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 24,893	$ 26,467
Accumulated Amortization	(14,204)	(13,266)
Net Carrying Amount	10,689	13,201
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	17,997	19,571
Accumulated Amortization	(9,414)	(9,194)
Net Carrying Amount	8,583	10,377
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	5,187	5,187
Accumulated Amortization	(3,646)	(3,225)
Net Carrying Amount	1,541	1,962
Trade name
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,709	1,709
Accumulated Amortization	(1,144)	(847)
Net Carrying Amount	$ 565	$ 862

Purchased Intangible Assets a_4

Purchased Intangible Assets and Goodwill - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Intellectual Property
Acquired Finite-Lived Intangible Assets [Line Items]
Impairment of indefinite-lived intangible assets	$ 0.4	$ 0	$ 0.4	$ 0
Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life			3 years
Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life			10 years

Purchased Intangible Assets a_5

Purchased Intangible Assets and Goodwill - Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Purchased intangible assets amortization expense	$ 607	$ 586	$ 2,083	$ 1,512

Purchased Intangible Assets a_6

Purchased Intangible Assets and Goodwill - Schedule of Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2024 (remainder of the year)	$ 607
2025	2,343
2026	1,874
2027	1,561
2028	1,561
Thereafter	2,743
Net Carrying Amount	$ 10,689	$ 13,201

Purchased Intangible Assets a_7

Purchased Intangible Assets and Goodwill - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 53,991
Effects of foreign currency translation	499
Other	510
Ending balance	$ 55,000

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Payables and Accruals [Abstract]
Warrant liability	$ 8,592	$ 2,829
Debt conversion liability	5,773	0
Accrued taxes	4,305	4,088
Accrued hosting and third-party licenses	2,800	4,374
Accrued outside services and consulting	2,138	3,507
Accrued interest	1,492	850
Litigation settlement	0	75,000
Accrued contingent consideration	0	4,420
Other accrued expenses	2,710	8,610
Total	$ 27,810	$ 103,678

Debt - Narrative (Details)

Debt - Narrative (Details) $ / shares in Units, shares in Millions, converted_share in Millions		9 Months Ended
	Mar. 24, 2022 USD ($) converted_share $ / shares shares	Oct. 31, 2023 USD ($) shares	Sep. 23, 2023 USD ($)
First Citizen Bank & Trust Company | WSJ Prime Rate
Debt Instrument [Line Items]
Basis spread on variable interest rate, minus (percent)		1%
Revolving Loan | First Citizen Bank & Trust Company
Debt Instrument [Line Items]
Credit facility maximum borrowing capacity		$ 30,000,000
Amount drawn under credit facility		$ 0
Silver Lake Warrants
Debt Instrument [Line Items]
Number of securities called by warrants (in shares) | shares	7.5	7.5
Make-whole fundamental change scenarios, issuance of stock as percentage of outstanding shares for requirement of shareholder approval	20%
Initial Notes | Convertible senior notes
Debt Instrument [Line Items]
Aggregate principal amount	$ 250,000,000
Initial conversion rate	50
Principal amount for conversion	$ 1,000
Price per share conversion (in dollars per share) | $ / shares	$ 20
Number of equity instruments upon conversion (in shares) | converted_share	20
Additional Notes | Convertible senior notes
Debt Instrument [Line Items]
Aggregate principal amount			$ 150,000,000
Debt issuance costs			$ 4,100,000
2029 Notes
Debt Instrument [Line Items]
Make-whole fundamental change scenarios, issuance of stock as percentage of outstanding shares for requirement of shareholder approval	20%
Shares issuable upon conversion (in shares) | shares	1.4
Value of shares issuable upon conversion	$ 6,100,000
2029 Notes | Convertible senior notes
Debt Instrument [Line Items]
Conversion percentage of par value	98%
Interest rate (percent)	3.95%
Optional in kind interest (percent)	5.50%
Debt discount amortization period	5 years
Effective interest rate (percent)	7.60%

Debt - Balances (Details)

Debt - Balances (Details) - Initial Notes - Convertible senior notes - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Debt Instrument [Line Items]
2029 Notes principal	$ 400,000	$ 250,000
Unamortized debt issuance costs, debt discount, and associated derivatives	(43,355)	(39,597)
Carrying value	$ 356,645	$ 210,403

Debt - Interest Expense (Detail

Debt - Interest Expense (Details) - Initial Notes - Convertible senior notes - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Interest Expenses [Line Items]
Contractual interest expense	$ 3,111	$ 2,469	$ 8,049	$ 5,953
Amortization of debt discount	2,443	1,967	6,441	4,634
Total interest expense	$ 5,554	$ 4,436	$ 14,490	$ 10,587

Debt - Debt Conversion Liabilit

Debt - Debt Conversion Liability Measurement Input (Details)	Oct. 31, 2023	Sep. 22, 2023
Fair value of common stock (in dollars per share)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt conversion liability, measurement input	7.41	8.44
Conversion price (in dollars per share)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt conversion liability, measurement input	20	20
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt conversion liability, measurement input	0.475	0.475
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt conversion liability, measurement input	0.047	0.045
Corporate bond yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt conversion liability, measurement input	0.214	0.205
Coupon interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt conversion liability, measurement input	0.0395	0.0395

Debt - Changes in Fair Value Me

Debt - Changes in Fair Value Measurements of Derivative Liability (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Debt Conversion Liability
Embedded Derivative [Line Items]
Change in fair value of debt conversion liability	$ 287	$ 0	$ 287	$ 0

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations - Deferred Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue recognized from deferred revenue	$ 80,407	$ 75,929	$ 153,729	$ 137,257

Deferred Revenue and Performa_4

Deferred Revenue and Performance Obligations - Performance Obligations (Details) $ in Millions	Oct. 31, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligations	$ 554.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation (percent)	54%
Revenue, remaining performance obligation, period	12 months

Geographical Information (Detai

Geographical Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 109,849	$ 101,072	$ 320,992	$ 293,046
United States
Disaggregation of Revenue [Line Items]
Revenue	70,312	66,902	205,067	191,129
Others
Disaggregation of Revenue [Line Items]
Revenue	$ 39,537	$ 34,170	$ 115,925	$ 101,917
Revenue | Geographic Concentration | United States
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	64%	66%	64%	65%
Revenue | Geographic Concentration | Others
Disaggregation of Revenue [Line Items]
Concentration risk (percent)	36%	34%	36%	35%

Leases - Narrative (Details)

Leases - Narrative (Details)	Oct. 31, 2023 extension_option
Minimum
Lessee, Lease, Description [Line Items]
Number of lease extension options	1
Maximum
Lessee, Lease, Description [Line Items]
Operating renewal term (in years)	7 years

Leases - Components of Leases a

Leases - Components of Leases and Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Operating Leases
Operating lease right-of-use assets	$ 25,296		$ 25,296		$ 22,768
Operating lease liabilities, current portion	7,396		7,396		9,240
Operating lease liabilities, net of current portion	38,060		38,060		37,924
Total operating lease liabilities	45,456		45,456		$ 47,164
Lease Cost
Operating lease cost	2,117	$ 2,337	6,526	$ 7,589
Short-term operating lease costs	146	118	387	317
Sublease income	$ (98)	$ 0	$ (293)	$ 0

Leases - Future Maturities of O

Leases - Future Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Jan. 31, 2023
Maturities of Operating Lease Liabilities
2024 (remainder of the year)	$ 2,377
2025	8,766
2026	8,694
2027	7,947
2028	7,863
Thereafter	17,484
Total lease payments	53,131
Less imputed interest	(7,675)
Present value of lease liabilities	$ 45,456	$ 47,164

Leases - Supplemental Informati

Leases - Supplemental Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022	Jan. 31, 2023
Lease Term and Discount Rate
Weighted-average remaining operating lease term	6 years 1 month 6 days		6 years 1 month 6 days		6 years 8 months 12 days
Weighted-average operating lease discount rate (percent)	5.10%		5.10%		4.80%
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases	$ 3,143	$ 2,639	$ 10,671	$ 9,461
New right-of-use assets obtained in exchange for lease liabilities:
Operating leases obtained	$ 427	$ 799	$ 7,400	$ 799

Commitments and Contingencies (

Commitments and Contingencies (Details)	1 Months Ended				2 Months Ended
	Aug. 30, 2023 USD ($)	Feb. 28, 2023 USD ($)	Jul. 31, 2020 lawsuit	Sep. 30, 2019 lawsuit	Mar. 31, 2021 lawsuit	Jun. 30, 2020 lawsuit	May 31, 2020 lawsuit	Oct. 31, 2023 USD ($) vendor	Jan. 31, 2023 USD ($)
Other Commitments [Line Items]
Litigation settlement, amount awarded to other party		$ 2,000,000
Cloud computing services
Other Commitments [Line Items]
Contractual obligation								$ 6,900,000
Number of vendors related to contractual obligation | vendor								1
Putative securities class action
Other Commitments [Line Items]
Number of lawsuits filed | lawsuit							2
Number of lawsuits consolidated | lawsuit			2
Litigation settlement, amount awarded to other party	$ 75,500,000
Payments for legal settlements funded by insurance proceeds	$ 7,200,000
Stockholder derivative lawsuits, CA
Other Commitments [Line Items]
Number of lawsuits filed | lawsuit				2
Stockholder Derivative Lawsuits, Delaware
Other Commitments [Line Items]
Number of lawsuits filed | lawsuit						2
Stockholder derivative lawsuits, delaware chancery court
Other Commitments [Line Items]
Number of lawsuits filed | lawsuit					2
Certain facility lease agreements | Irrevocable letters of credit
Other Commitments [Line Items]
Letters of credit available								$ 4,500,000	$ 4,500,000
Letters of credit outstanding								$ 0	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Income Tax Disclosure [Abstract]
Loss before income taxes	$ (5,162)	$ (36,726)	$ (45,963)	$ (88,967)
Income tax provision	$ 340	$ 308	$ 1,396	$ 1,145
Effective tax rate	(6.60%)	(0.80%)	(3.00%)	(1.30%)

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details)	Oct. 31, 2023 vote $ / shares shares
Class of Stock [Line Items]
Preferred stock authorized (in shares)	10,000,000
Preferred stock par value (in dollars per share) | $ / shares	$ 0.0001
Preferred stock issued (in shares)	0
Preferred stock outstanding (in shares)	0
Class A common stock
Class of Stock [Line Items]
Number of votes for each share of stock held (in votes) | vote	1
Common stock authorized (in shares)	500,000,000
Common stock par value (in dollars per share) | $ / shares	$ 0.0001
Common stock issued (in shares)	135,000,000
Common stock outstanding (in shares)	135,000,000
Class B common stock
Class of Stock [Line Items]
Number of votes for each share of stock held (in votes) | vote	10
Common stock authorized (in shares)	500,000,000
Common stock par value (in dollars per share) | $ / shares	$ 0.0001
Common stock issued (in shares)	8,100,000
Common stock outstanding (in shares)	8,100,000

Stockholders' Equity - Componen

Stockholders' Equity - Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Components of accumulated other comprehensive loss
Beginning balance	$ 112,727	$ 192,665	$ 97,160	$ 170,607
Foreign currency translation adjustment	(696)	(973)	(1,383)	(1,648)
Unrealized gain on available-for-sale securities	(18)	(337)	494	(1,013)
Ending balance	125,577	183,904	125,577	183,904
AOCI
Components of accumulated other comprehensive loss
Beginning balance	(1,094)	(1,459)	(919)	(108)
Ending balance	(1,808)	$ (2,769)	(1,808)	$ (2,769)
Foreign Currency Translation Adjustment
Components of accumulated other comprehensive loss
Beginning balance			(343)
Foreign currency translation adjustment			(1,383)
Ending balance	(1,726)		(1,726)
Unrealized Loss on Available-for-Sale Securities
Components of accumulated other comprehensive loss
Beginning balance			(576)
Unrealized gain on available-for-sale securities			494
Ending balance	$ (82)		$ (82)

Employee Stock Plans - Narrativ

Employee Stock Plans - Narrative (Details) shares in Thousands	3 Months Ended	9 Months Ended
	Apr. 30, 2023 shares	Oct. 31, 2023 purchase_period shares	Sep. 30, 2023 tranche
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	9,600	420
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of tranches | tranche			2
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of tranches | tranche			3
2018 Equity Incentive Plan | Class A common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved and available for issuance (in shares)		26,800
2006 Stock Plan and 2015 Equity Incentive Plan | Stock Options and RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate equity awards outstanding (in shares)		4,000
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved and available for issuance (in shares)		4,900
ESPP offering period (in months)		24 months
Number of purchase periods in offering period | purchase_period		4
Term of purchase period (in months)		6 months
Purchase price, percentage of fair market value		85%

Employee Stock Plans - Stock Op

Employee Stock Plans - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 31, 2023 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) $ / shares shares
Shares Subject To Outstanding Stock Options
Outstanding, beginning balance (in shares) | shares	7,761
Exercised (in shares) | shares	(215)
Cancelled (in shares) | shares	(775)
Forfeited (in shares) | shares	(183)
Outstanding, ending balance (in shares) | shares	6,588	7,761
Exercisable (in shares) | shares	3,017
Vested and expected to vest (in shares) | shares	6,563
Weighted-Average Exercise Price
Weighted average exercise price, beginning balance (in dollars per share) | $ / shares	$ 9.28
Exercised (in dollars per share) | $ / shares	4.57
Cancelled (in dollars per share) | $ / shares	13.28
Forfeited (in dollars per share) | $ / shares	12.67
Weighted average exercise price, ending balance (in dollars per share) | $ / shares	8.87	$ 9.28
Exercisable (in dollars per share) | $ / shares	3.36
Vested and expected to vest (in dollars per share) | $ / shares	$ 8.85
Average Remaining Contractual Term (Years)
Average remaining contractual term (years), outstanding	4 years	5 years
Average remaining contractual term (years), exercisable	1 year 8 months 12 days
Average remaining contractual term (years), vested and expected to vest	3 years 10 months 24 days
Aggregate Intrinsic Value
Aggregate intrinsic value, outstanding | $	$ 12,205	$ 14,505
Aggregate intrinsic value, exercisable | $	12,205
Aggregate intrinsic value, vested and expected to vest | $	$ 12,205

Employee Stock Plans - Grant Da

Employee Stock Plans - Grant Date Fair Value and Intrinsic Value of Options Exercised (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Share-Based Payment Arrangement [Abstract]
Weighted-average grant date fair value per share of options granted during each respective period (in dollars per share)	$ 0	$ 0	$ 0	$ 5.54
Aggregate intrinsic value of options exercised during each respective period	$ 73	$ 356	$ 1,104	$ 2,386

Employee Stock Plans - RSU and

Employee Stock Plans - RSU and PSU Activity (Details) - $ / shares shares in Thousands	3 Months Ended	9 Months Ended
	Apr. 30, 2023	Oct. 31, 2023
RSUs
Number Outstanding
Outstanding, beginning balance (in shares)	12,504	12,504
Granted (in shares)		7,785
Vested (in shares)		(6,224)
Forfeited (in shares)		(1,398)
Outstanding, ending balance (in shares)		12,667
Weighted-Average Grant Date Fair Value
Outstanding, beginning balance (in dollars per share)	$ 12.98	$ 12.98
Granted (in dollars per share)		8.12
Vested (in dollars per share)		11.87
Forfeited (in dollars per share)		12.92
Outstanding, ending balance (in dollars per share)		$ 10.54
PSUs
Number Outstanding
Outstanding, beginning balance (in shares)	2,905	2,905
Granted (in shares)	9,600	420
Vested (in shares)		(240)
Forfeited (in shares)		(525)
Outstanding, ending balance (in shares)		2,560
Weighted-Average Grant Date Fair Value
Outstanding, beginning balance (in dollars per share)	$ 15.21	$ 15.21
Granted (in dollars per share)		10.24
Vested (in dollars per share)		15.21
Forfeited (in dollars per share)		15.21
Outstanding, ending balance (in dollars per share)		$ 14.40

Employee Stock Plans - Valuatio

Employee Stock Plans - Valuation Assumptions for Estimated Fair Value of ESPP (Details) - 2018 ESPP - $ / shares	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of common stock (in dollars per share)	$ 11.55	$ 8.91	$ 11.55	$ 8.91
Expected volatility, minimum (percent)	37.10%	44.40%	37.10%	44.40%
Expected volatility, maximum (percent)	45.70%	52.30%	45.70%	52.30%
Risk-free interest rate, minimum (percent)	3%	2.30%	3%	2.30%
Risk-free interest rate, maximum (percent)	4.80%	3.20%	4.80%	3.20%
Expected dividend yield (percent)	0%	0%	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years	2 years	2 years	2 years

Employee Stock Plans - Stock-Ba

Employee Stock Plans - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Cost of Revenue
Stock-based compensation expense	$ 26,101	$ 29,007	$ 77,973	$ 80,045
Cost of subscription revenue
Cost of Revenue
Stock-based compensation expense	2,350	2,437	6,889	6,517
Cost of professional services revenue
Cost of Revenue
Stock-based compensation expense	2,747	3,479	8,997	10,186
Research and development
Cost of Revenue
Stock-based compensation expense	7,165	7,536	20,661	20,967
Sales and marketing
Cost of Revenue
Stock-based compensation expense	8,191	10,188	24,857	27,603
General and administrative
Cost of Revenue
Stock-based compensation expense	$ 5,648	$ 5,367	$ 16,569	$ 14,772

Employee Stock Plans - Unrecogn

Employee Stock Plans - Unrecognized Compensation Cost (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2023 USD ($)
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, stock options	$ 2,197
Weighted-average recognition period (in years)	1 year 2 months 12 days
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 114,874
Weighted-average recognition period (in years)	1 year 10 months 24 days
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 21,049
Weighted-average recognition period (in years)	1 year 3 months 18 days
2018 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 5,722
Weighted-average recognition period (in years)	9 months 18 days

Warrants to Purchase Shares o_3

Warrants to Purchase Shares of Common Stock - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions		3 Months Ended	9 Months Ended
	Sep. 23, 2023	Oct. 31, 2023	Oct. 31, 2023	Jan. 31, 2023	Mar. 24, 2022
Class of Warrant or Right [Line Items]
Warrant liability		$ 8,592	$ 8,592	$ 2,829
Reclassification of warrants, net of allocated debt issuance costs, to Accrued expenses and other current liabilities		$ 7,073	$ 7,073
Silver Lake Warrants
Class of Warrant or Right [Line Items]
Number of securities called by warrants (in shares)		7.5	7.5		7.5
Warrants term					7 years
Make-whole fundamental change scenarios, issuance of stock as percentage of outstanding shares for requirement of shareholder approval					20%
Warrants classified as liability (in shares)	4.7				2.8
Warrant liability					$ 12,000
Reclassification of warrants, net of allocated debt issuance costs, to Accrued expenses and other current liabilities	$ 7,700
Silver Lake Warrants | Warrants, tranche one
Class of Warrant or Right [Line Items]
Number of securities called by warrants (in shares)					2.5
Exercise price of warrants (in dollars per share)					$ 20
Silver Lake Warrants | Warrants, tranche two
Class of Warrant or Right [Line Items]
Number of securities called by warrants (in shares)					2.5
Exercise price of warrants (in dollars per share)					$ 22
Silver Lake Warrants | Warrants, tranche three
Class of Warrant or Right [Line Items]
Number of securities called by warrants (in shares)					2.5
Exercise price of warrants (in dollars per share)					$ 24

Warrants to Purchase Shares o_4

Warrants to Purchase Shares of Common Stock - Valuation Inputs (Details) - Warrant liability	Oct. 31, 2023	Sep. 22, 2023	Jan. 31, 2023
Fair value of common stock (in dollars per share)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	7.41	8.44	7.24
Exercise price (in dollars per share) | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	20	20	22
Exercise price (in dollars per share) | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	24	24	24
Expected volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.424	0.422	0.412
Expected term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input, term	5 years 4 months 24 days	5 years 6 months	6 years 2 months 12 days
Risk-free interest rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0.048	0.046	0.036
Expected dividend yield
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement input	0	0	0

Warrants to Purchase Shares o_5

Warrants to Purchase Shares of Common Stock - Realized Losses and Gains on the Liability-Classified Warrants (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Silver Lake Warrants
Class of Warrant or Right [Line Items]
Change in fair value of warrant liability	$ 6,710	$ 452	$ 1,954	$ 9,348

Net Loss Per Share - Basic and

Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022	Oct. 31, 2023	Oct. 31, 2022
Numerator:
Net loss	$ (5,502)	$ (37,034)	$ (47,359)	$ (90,112)
Denominator:
Weighted-average common shares outstanding, basic (in shares)	141,488	132,579	138,789	130,461
Weighted-average common shares outstanding, diluted (in shares)	141,488	132,579	138,789	130,461
Net loss per share, basic (in dollars per share)	$ (0.04)	$ (0.28)	$ (0.34)	$ (0.69)
Net loss per share, diluted (in dollars per share)	$ (0.04)	$ (0.28)	$ (0.34)	$ (0.69)

Net Loss Per Share - Potentiall

Net Loss Per Share - Potentially Dilutive Securities Not Included in the Diluted Per Share (Details) - shares shares in Thousands	9 Months Ended
	Oct. 31, 2023	Oct. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	49,913	45,453
2029 Notes conversion
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	20,000	12,500
Unvested RSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	12,667	14,234
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	7,500	7,500
Issued and outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	6,588	7,875
Unvested PSUs issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	2,560	2,905
Shares committed under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities not included in the diluted per share calculation (in shares)	598	439